Home care has evolved into a highly technical support system caring for the more acutely ill patient who requires specialized medical attention. Almost every drug is a candidate for home-care administration if adequate patient selection and monitoring criteria are met. Home parenteral antimicrobial therapy has progressed beyond simple intravenous (IV) drip administration. New routes and techniques, and unusual doses and intervals are commonly encountered. Newer infusion devices have enabled antibiotic and other therapies to be accomplished more easily. Parenteral chemotherapy at home has been given by some unusual routes and administered continuously. Management of the potentially severe side effects of antineoplastic therapy has also been successfully accomplished in the home. This article addresses the considerations for initiating home parenteral therapy and provides an overview of the management of antimicrobial and antineoplastic therapies at home.
Get full access to this article
View all access options for this article.
References
1.
Brown TR, Smith MC: Handbook of Institutional Pharmacy Practice. Baltimore, MD, Williams & Witkins, 1986
2.
Grealy MR: Overview of the Medicare Castastrophic Coverage Act of 1988 and its impact on health-care delivery. Am J Hosp Pharm46:S4-S9, 1989 (suppl)
3.
Morse GD, Apicella MA, Walshe JJ: Absorption of intraperitoneal antibiotics. Drug Intell Clin Pharm22:58-61, 1988
4.
Hodson ME, Penketh Arl, Batten JC: Aerosol carbenicillin and gentamicin treatment of pseudomonas aeruginosa infection in patients with cystic fibrosis. Lancet:1137-1139, 1981
5.
MacLusky I., Levison H., Gold R., et al: Inhaled antibiotics in cystic fibrosis: Is there a therapeutic effect?J Pediatr108:861-865, 1986
6.
Kelly HW, Lovato C.: antibiotic use in cystic fibrosis. Drug Intell Clin Pharm18:772-783, 1984
7.
Stephens D., Garey N., Isles A., et al: Efficacy of inhaled tobramycin in the treatment of pulmonary exacerbations in children with cystic fibrosis. Pediatr Infect Dis2:209-211, 1983
8.
Alexander DP: Respiratory tract infections, in Yee Young L, Koda-Kimble MA (ed): Applied Therapeutics-The Clinical Use of Drugs (ed 4). Vancouver, British Columbia, Applied Therapeutics Inc, 1988, pp 803-827
9.
Esau R., Hamilton D., Davidson Agf, et al: Toxicity of high dose tobramycin therapy in cystic fibrosis patients. Can J Hosp Pharm40:203-208, 1987
10.
Meyers JD, Wade JC, McGuffin RW, et al: The use of acyclovir for cytomegalovirus infections in the immunocompromised host. J Antimicrob Chemother12:181-193, 1983
11.
Verpooten GA , Giuliano RA, Verbist L., et al: Once-daily dosing decreases renal accumulation of gentamicin and netilmicin. Clin Pharm Ther45:22-27, 1989
12.
Powell SH, Thompson WL, Luthe MA, et al: Once-daily vs. continuous aminoglycoside dosing: Efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin . J Infect Dis147:918-932, 1983
13.
Stratford BC , Dixson S., Cobcroft AJ: Serum levels of gentamicin and tobramycin after slow intravenous bolus injection. Lancet1:378-379, 1974
14.
Blouin RA, Rowse-Brouwer KL, Record KE, et al: Amikacin pharmacokinetics in morbidly obese patients undergoing gastric-bypass surgery. Clin Pharm4:70-72, 1985
15.
Mendelson J. , Portnoy J., Dick V., et al: Safety of the bolus administration of gentamicin. Antimicrob Agents Chemother9:633-638, 1976
16.
Raine Pam, Young DG, McAllister TA, et al: Tobramycin in pediatric use. J Infect Dis134:S165-S169, 1976
17.
Gillett AP, Falk RH, Andrews J., et al: Rapid intravenous injection of tobramycin: Suggested dosage schedule and concentrations in serum. J Infect Dis134:S110-S113, 1976
18.
Dobbs SM, Mawer GE: Intravenous injection of gentamicin and tobramycin without impairment of hearing . J Infect Dis134:S114-S117, 1976 (suppl)
19.
LeBel M., Spino M.: Pulse dosing versus continuous infusion of antibiotics. Clin Pharmacokinetics14:71-95, 1988
20.
Danziger LH : Controversies in antimicrobial therapy: Innovative methods of administration. Am J Hosp Pharm43:646-652, 1986
21.
Colding H., Andersen GE: Administration of gentamicin and ampicillin by continuous intravenous infusion to newborn infants during parenteral nutrition. Scand J Infect Dis14:61-65, 1982
22.
Kwan JW: High-technology IV infusion devices. Am J Hosp Pharm46:320-335, 1989
23.
Perry CR, Rice S., Ritterbusch JK, et al: Local administration of antibiotics with an implantable osmotic pump. Clin Orthop192:284-290,1985
24.
Gentry LO: Home management of osteomyelitis. Bull NY Acad Med64:565-569, 1988
25.
Baptista RJ , Mitrano FP: Experience with 211 courses of home intravenous antimicrobial therapy. Am J Hosp Pharm46:315-316, 1989
26.
Brown JM: Innovative antibiotic therapy at home. J Intravenous Nursing11:397-401, 1988
27.
Lokich JJ, Perri J., Bothe A., et al: Cancer chemotherapy via ambulatory infusion pump. Am J Clin Oncol6:355-363,1983
28.
Carlson RW, Sikic BI: Continuous infusion or bolus injection in cancer chemotherapy. Ann Intern Med99:823-833, 1983
29.
Dorr RT, Fritz MS: Cancer Chemotherapy Handbook. New York, NY, Elsevier, 1983, pp 51-54
Cozzi E., Hagle M., McGregor ML, et al: Nursing management of patients receiving hepatic arterial chemotherapy through an implanted infusion pump. Cancer Nursing:7: 229-234, 1984
32.
Brenner DE: Intraperitoneal chemotherapy: A review. J Clin Oncol4:1135-1147, 1986
33.
Merrifield KR, Chaffee BJ: Recent advances in the management of nausea and vomiting caused by antineoplastic agents. Clin Pharm8:187-199, 1989
34.
Gralla RJ, Tyson LB, Kris MG, et al: The management of chemotherapy-induced nausea and vomiting. Med Clin North Am71:289-301,1987
35.
Wang B.: Malignancy-associated hypercalcemia—Its treatment. On Continuing Practice15:35-38, 1988
36.
Burns-Schaiff RA, Hall TG, Bar RS: Medical treatment of hypercalcemia. Clin Pharm8:108-121, 1989
